Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study. (Q48461750)

11 February 2018

title

Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study. (English)

1 reference

11 February 2018

1 reference

8

1 reference

11 February 2018

Claire Bonithon-Kopp

5

object named as

Claire Bonithon-Kopp

1 reference

11 February 2018

author name string

Corine Aboa-Eboulé

1

1 reference

11 February 2018

Christine Binquet

2

1 reference

11 February 2018

Agnès Jacquin

3

1 reference

11 February 2018

Marie Hervieu

4

1 reference

11 February 2018

Jérôme Durier

6

1 reference

11 February 2018

Maurice Giroud

7

1 reference

11 February 2018

publication date

24 June 2012

1 reference

11 February 2018

published in

Journal of Neurology

1 reference

11 February 2018

volume

260

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

30-37

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-012-6580-9

exact match

0 references

cites work

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Favorable outcome of ischemic stroke in patients pretreated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Rising statin use and effect on ischemic stroke outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Statin use and sex-specific stroke outcomes in patients with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

The modified National Institutes of Health Stroke Scale: its time has come

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

The effect of statin pretreatment on infarct volume in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Statistical analysis of the primary outcome in acute stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6580-9

Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke

21 January 2018

1 reference

12 December 2020

Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events

1 reference

12 December 2020

Effect of prior medical treatments on ischemic stroke severity and outcome.

1 reference

12 December 2020

Effect of pretreatment with statins on ischemic stroke outcomes

1 reference

12 December 2020

Better outcome after stroke with higher serum cholesterol levels

1 reference

12 December 2020

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

1 reference

12 December 2020

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

12 December 2020

The beneficial effect of statins treatment by stroke subtype

1 reference

12 December 2020

10.1007/S00415-012-6580-9

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018